ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,030 filers reported holding ASTRAZENECA PLC in Q1 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,290,219 | -5.4% | 78,119 | -0.0% | 1.48% | +2.3% |
Q2 2023 | $5,591,263 | +402.4% | 78,123 | +387.2% | 1.45% | +367.4% |
Q1 2023 | $1,112,920 | +0.6% | 16,034 | -1.8% | 0.31% | -1.0% |
Q4 2022 | $1,106,496 | +12.9% | 16,320 | +1.6% | 0.31% | +7.6% |
Q3 2022 | $980,000 | -7.1% | 16,062 | +0.6% | 0.29% | -7.6% |
Q2 2022 | $1,055,000 | +9.1% | 15,963 | +9.5% | 0.32% | +42.5% |
Q1 2022 | $967,000 | +45.6% | 14,576 | +27.9% | 0.22% | +57.9% |
Q4 2021 | $664,000 | -3.1% | 11,400 | 0.0% | 0.14% | -10.8% |
Q3 2021 | $685,000 | +0.3% | 11,400 | 0.0% | 0.16% | +0.6% |
Q2 2021 | $683,000 | +18.4% | 11,400 | -1.9% | 0.16% | +9.9% |
Q1 2021 | $577,000 | +3.8% | 11,615 | +4.5% | 0.14% | 0.0% |
Q4 2020 | $556,000 | -62.8% | 11,115 | -59.2% | 0.14% | -68.6% |
Q3 2020 | $1,493,000 | +6.6% | 27,253 | +3.0% | 0.45% | -2.8% |
Q2 2020 | $1,400,000 | +237.3% | 26,463 | +184.6% | 0.46% | +161.2% |
Q1 2020 | $415,000 | +29.3% | 9,297 | +44.5% | 0.18% | +69.5% |
Q4 2019 | $321,000 | – | 6,434 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |